Genetec Corp
TSE:4492
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
JP |
Genetec Corp
TSE:4492
|
10.6B JPY | 23.8 | ||
IE |
Accenture PLC
NYSE:ACN
|
191.1B USD | 21.5 | ||
IN |
Tata Consultancy Services Ltd
NSE:TCS
|
13.9T INR | 35.9 | ||
US |
International Business Machines Corp
NYSE:IBM
|
151.9B USD | 11.5 | ||
IN |
Infosys Ltd
NSE:INFY
|
5.9T INR | 28.9 | ||
IN |
HCL Technologies Ltd
NSE:HCLTECH
|
3.7T INR | 19.5 | ||
FR |
Capgemini SE
PAR:CAP
|
34.9B EUR | 43.1 | ||
US |
Gartner Inc
NYSE:IT
|
33.5B USD | 31.4 | ||
US |
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
32.9B USD | 24.7 | ||
JP |
Fujitsu Ltd
TSE:6702
|
4.6T JPY | 246.5 | ||
IN |
Wipro Ltd
NSE:WIPRO
|
2.4T INR | 18.1 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.